These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9845081)

  • 1. Hyperfractionation as an effective way of overcoming radioresistance.
    Denekamp J; Daşu A; Waites A; Littbrand B
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):705-9. PubMed ID: 9845081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superfractionation as a potential hypoxic cell radiosensitizer: prediction of an optimum dose per fraction.
    Daşu A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1083-94. PubMed ID: 10192360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into factors influencing the clinically relevant oxygen enhancement ratio.
    Daşu A; Denekamp J
    Radiother Oncol; 1998 Mar; 46(3):269-77. PubMed ID: 9572620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters.
    Carlson DJ; Stewart RD; Semenenko VA
    Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.
    Wenzl T; Wilkens JJ
    Radiat Oncol; 2011 Dec; 6():171. PubMed ID: 22172079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic optimization of a linear-quadratic model with incomplete repair and volume-dependent sensitivity and repopulation.
    Wein LM; Cohen JE; Wu JT
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1073-83. PubMed ID: 10863081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
    Stuschke M; Budach V; Stüben G; Streffer C; Sack H
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA; Millar WT; Visser AG; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
    Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume dependence in hypoxia-targeted dose escalation.
    Chvetsov AV; Zeng J; Rajendran JG
    Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
    Harriss-Phillips WM; Bezak E; Potter A
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of hypersensitivity to fractionated low-dose radiation exposure.
    Smith LG; Miller RC; Richards M; Brenner DJ; Hall EJ
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):187-91. PubMed ID: 10477023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
    Malaise EP; Lambin P; Joiner MC
    Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
    Zhang H; Zhong H; Barth RF; Cao M; Das IJ
    Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose fractionation effects in primary and metastatic human uveal melanoma cell lines.
    van den Aardweg GJ; Kiliç E; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4660-4. PubMed ID: 14578382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for increased tolerance of rat spinal cord with decreasing fraction doses below 2 Gy.
    Ang KK; van der Kogel AJ; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):105-10. PubMed ID: 3967980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
    Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
    Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.